IEP SHAREHOLDER ALERT: Jakubowitz Law Reminds Icahn Enterprises Shareholders of a Lead Plaintiff Deadline of July 10, 2023
NEW YORK, June 14, 2023 (GLOBE NEWSWIRE) -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Icahn Enterprises L.P. (NASDAQ: IEP).
To receive updates on the lawsuit, fill out the form:
https://claimyourloss.com/securities/icahn-enterprises-class-action-loss-submission-form/?id=40775&from=3
The lawsuit seeks to recover losses for shareholders who purchased Icahn Enterprises between August 2, 2018 and May 9, 2023.
Shareholders interested in acting as a lead plaintiff representing the class of wronged shareholders have until July 10, 2023 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
According to a filed complaint, Icahn Enterprises L.P. issued materially false and/or misleading statements and/or failed to disclose that: (i) Icahn Enterprises was inflating its net asset value; (ii) the Company was using money taken in from new investors to pay out dividends to old investors; (iii) as a result, the Company would become the subject of criminal and/or regulatory scrutiny; and (iv) as a result of the foregoing, Defendant’s positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (628) 895-0423
F: (212) 537-5887
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.